Home » American Liberty Petroleum to Acquire Avant Diagnostics, Bring OvaDx Test to Market

American Liberty Petroleum to Acquire Avant Diagnostics, Bring OvaDx Test to Market

Sep 18, 2014
|
staff reporter

NEW YORK (GenomeWeb) – American Liberty Petroleum Corp. has announced plans to acquire Avant Diagnostics, a Scottsdale, Ariz.-based company seeking to commercialize OvaDx, a microarray-based test for early stage ovarian cancer detection.

According to an 8-K filing with the US Securities and Exchange Commission, American Liberty Petroleum Corp. has signed a letter of intent to buy Avant for an undisclosed sum. The companies expect the deal to close on or about Oct. 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

An Expensive Deal

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Figuring Out Who It'll Work For

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

This Week in Nature

In Nature this week: paternal age associated with de novo mutations in children, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.